Zobrazeno 1 - 10 of 12 pro vyhledávání: '"S V, Tkacheva"'
1
Akademický článek
Non-invasive methods for the diagnosis of liver fibrosis in chronic HCV-infection
Autor: A. I. Fazul’zyanova, A. K. Husainova, S. V. Tkacheva, F. M. Yakupova
Publikováno v: Журнал инфектологии, Vol 13, Iss 1, Pp 58-65 (2021)
Objective: to study the values of fibrosis indices and transient elastometry in patients with chronic HCV infection who received antiviral therapy.Materials and methods: The study included 64 patients with chronic HCV infection who received antiviral
Externí odkaz: https://doaj.org/article/867dd2702b334af3a190314b7c163278
Zobrazit plný text záznamu
2
Akademický článek
Clinical-Laboratory Effectiveness of Immune-Replacement Therapy of Hemorrhagic Fever with Renal Syndrome
Autor: I. V. Nikolaeva, O. S. Mikhailova, S. V. Tkacheva, G. Sh. Isaeva, I. D. Reshetnikova, V. B. Ziatdinov, V. A. Aleshkin, A. G. Lyutov
Publikováno v: Проблемы особо опасных инфекций, Vol 0, Iss 4, Pp 81-85 (2021)
Currently, hemorrhagic fever with renal syndrome (HFRS) remains the most common natural focal disease of viral etiology in the Russian Federation. Effective antiviral drugs have not yet been developed. Pathogenetic and symptomatic drugs are mainly us
Externí odkaz: https://doaj.org/article/91b8b7ef48304519a528a48e3148fd8d
Zobrazit plný text záznamu
3
Non-invasive methods for the diagnosis of liver fibrosis in chronic HCV-infection
Autor: F. M. Yakupova, A. I. Fazul’zyanova, A. K. Husainova, S V Tkacheva
Publikováno v: Žurnal Infektologii, Vol 13, Iss 1, Pp 58-65 (2021)
Objective: to study the values of fibrosis indices and transient elastometry in patients with chronic HCV infection who received antiviral therapy.Materials and methods: The study included 64 patients with chronic HCV infection who received antiviral
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::051a41a85d80afb9fa39f7ee1c5b62b7
https://journal.niidi.ru/jofin/article/view/1178
Zobrazit plný text záznamu
6
Features of the course of manifest forms of acute hepatitis C
Autor: I I Rezyapova, A I Fazulzyanova, A I Rezyapova, S V Tkacheva, V Kh Fazylov, A A Zheglova, Z T Mukhamerdieva
Publikováno v: Kazanskij Medicinskij Žurnal, Vol 99, Iss 5, Pp 754-759 (2018)
Aim. To identify clinical, epidemiological and laboratory-instrumental features of acute hepatitis C at the present stage according to the infectious hospital data. Methods. The study included 111 patients with acute hepatitis C aged from 18 to 79 ye
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b90891f5569fbad28fab4922fb9e1726
https://doi.org/10.17816/kmj2018-754
Zobrazit plný text záznamu
8
[Evaluation of the antiviral therapy for chronic hepatitis C in patients unresponsive to previous treatment with regard to the interleukin-28B genotypes]
Autor: V Ch, Fazylov, S V, Tkacheva, E R, Manapova, F M, Jakupova
Publikováno v: Voprosy virusologii. 60(1)
The identification of the single nucleotide polymorphisms (SNP) at rs8099917 and rs12979860 loci of IL-28B gene is presently necessary for patients with the genotype HCV-1 to predict sustained viral response (SVR) in case of combined antiviral therap
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bf4403418e4a353a81d239ce558f7b85
https://pubmed.ncbi.nlm.nih.gov/26021070
Zobrazit plný text záznamu
9
[Applying of recombinant interleukin-1β to treat chronic hepatitis C for patients non-response to the previous antiviral therapy]
Autor: V Kh, Fazylov, S V, Tkacheva, É R, Manapova
Publikováno v: Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (10)
The search for rational treatment of CHC patients, non-response to the primary antiviral therapy especially with unfavorable genotypes for interleukin-28B, remains valid.To evaluate the efficacy and safety of recombinant IL-1β (Betaleukin) in combin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7976fea1881ab124f6e8a5354f178e82
https://pubmed.ncbi.nlm.nih.gov/25911934
Zobrazit plný text záznamu
10
[Pegylated intereferon hematological safety in comparison with standard]
Autor: V Kh, Fazylov, É R, Manapova, S V, Tkacheva, Iu M, Sozinova
Publikováno v: Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (6)
Comparative analysis of adverse hematologic effects in 135 patients with with chronic hepatits C on combined antiviral therapy of pegylated and "short lived" forms of alpha-interferon in combination with ribavirin was investigated. As a result of the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::995bd046e6254f3487d1705eff268664
https://pubmed.ncbi.nlm.nih.gov/23402198
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje